PD-1 inhibitor monotherapy versus combination therapy: A real-world study of patients with recurrent or metastatic advanced esophageal squamous cell carcinoma after first-line chemotherapy

Conclusion: Using PD-1 inhibitors in a combination treatment may improve PFS and OS, with acceptable toxicities.

Source: Journal of Cancer Research and Therapeutics - May 20, 2022 Category: Cancer & Oncology Authors: Guanli Yang Hongfu Sun Chunyang Zhou Nini Sun Lixia Xu Wei Huang Baosheng Li Source Type: research